Manal Haddad

19 October 2018

4 Reasons Why Amazon’s Foray into Pharma Might be Short Lived

Last fall, reports were abuzz with Amazon’s plan to start entering the pharma industry. Amazon relied on its ability to connect the consumer with the seller to work in the same way for the pharma industry.

4 Reasons Why Amazon’s Foray into Pharma Might be Short Lived Read More »

About Feature Writer

Manal is a seasoned business professional with over 30 years of applied experience in strategic planning, management, marketing, branding, and operations working for multi-national organizations in the FMCG and pharmaceutical industries and managing world-class brands and cross-cultural teams. His dedication to continuous learning and personal development has earned him a reputation for being a knowledgeable and insightful business leader. He believes that success is achieved through collaboration, innovation, and a commitment to excellence, and he applies this philosophy to every project he undertakes. His dedication to mentorship underscores his commitment to positively influencing the world around him. His coaching and mentoring style has been described as practical, insightful, and result-oriented. Manal’s vision for the future is to continue to innovate and inspire others to achieve their full potential while maintaining a healthy work-life balance that allows him to pursue his passions outside of business. He believes keeping a healthy lifestyle is essential to achieving long-term success and happiness, personally and professionally.

Manal Haddad

19 October 2018

4 Reasons Why Amazon’s Foray into Pharma Might be Short Lived

Recent Comments

Manal Haddad